TRANSCRIPT

Q1 2022 — Fixed income call transcript

Q1 2022PDF · 22 pages190 KB
Deutsche Bank AG
Deutsche Bank Q1 2022 Fixed Income Conference Call
Friday, 29 April 2022
Transcript
Speakers:
James von Moltke, Chief Financial Officer
Dixit Joshi, Group Treasurer
Philip Teuchner, Investor Relations

-- 1 of 22 --

Slide 1 – Results support trajectory to FY targets and ambitions
- Thank you, Philip, and welcome from me
- We are mindful that the war in Ukraine has been devastating for millions
of people, and continues to bring a high degree of uncertainty to the
world economy, to the market environment and to our clients
- We condemn the Russian invasion of Ukraine in the strongest possible
terms, and we support the German government and its allies in defend-
ing democracy and freedom
- We are not taking on any new business in Russia, nor with entities incor-
porated in Russia
- We have been clear that we are in the process of winding down our op-
erations, in line with our legal and regulatory obligations and are accom-
panying our clients in doing the same
- While this has the potential to impact our full year results in our important
measurement year, we believe we are on a good trajectory to reach our
2022 goals
- We delivered group revenues of 7.3 billion euros, an increase of 1% year
on year, even compared with a strong quarter in the prior year
- We saw revenue growth across all four core businesses, driven by busi-
ness momentum, market share gains and investments that will support
sustainable growth in 2022 and beyond
- This quarter, we generated a reported 8.1% return on tangible equity, up
on the first quarter of last year, despite a 28% increase in annual bank
levies, which are recognized in the first quarter
- We also improved our efficiency; post-tax profit was up 18% over a suc-
cessful prior year quarter, driven by positive operating leverage
- This brings our cost/income ratio down to 73%, four percentage points
lower compared to the prior year
- We are mindful that the current operating environment presents many
challenges, including on the cost front, and we will continue to focus on
cost discipline
- Finally, looking at our balance sheet, we are well-equipped to navigate
the current environment thanks to our high-quality loan book and tight
risk management
- Our capital position remained strong despite the impacts of the war in
Ukraine and facilitating business growth

-- 2 of 22 --

- Now let me take you through the progress on strategic priorities in our
core businesses on slide 2
Slide 2 – Progress on strategic priorities in core businesses
- In the Corporate Bank, business growth continued despite the more
challenging market, as we diligently executed on our strategy
- We saw this reflected in loan growth, which, alongside interest rate tail-
winds, contributed to an increase in net interest income. This, coupled
with cost discipline, helped us deliver operating leverage of 18% this
quarter
- In the Investment Bank, strong client activity in FIC supported revenues,
with year-on-year growth across institutional and corporate clients
- Advisory revenues were more than 80% higher year on year, partly off-
setting lower revenues in Equity and Debt Origination
- The Private Bank delivered its best quarter since we launched the trans-
formation, with pre-tax profit up more than half year on year to 419 mil-
lion euros. It also captured net new business of 13 billion euros, across
inflows into assets under management and loans
- Asset Management delivered revenue growth of 7% year on year, driven
by higher management fees, despite the volatile market environment
- At the same time, the business continued to invest in growth initiatives
and platform transformation
- The dynamics in all four core businesses provided a strong step-off point
to deliver on our 2022 targets
- Next, let me give you an update on Russia on slide 3
Slide 3 – Russia: impact continues to be carefully monitored
- We believe the investments we made in future proofing our business
meant we were well prepared as we entered this period of uncertainty
- This means we were ready to deal with not only the direct impacts of the
war in Ukraine, where we reduced our net loan exposure to Russia to be-
low 500 million euros by the end of this quarter, but also the second order
ones, and our investments in controls are a testament to this
- As a result, we executed diligently on sanctions implementation without
any major issues, and managed the financial aspects of these sanctions

-- 3 of 22 --

- As it stands, we operate under a heightened alert status, and we are con-
tinuously adapting our controls to the evolving landscape
- Despite the uncertainties of the current situation, we have not seen any
major disruptions to our businesses, even with all the added safeguards
we have put in place
- While it is too early to quantify the potential long-term impacts of the
war, we believe our conservative balance sheet and transformed busi-
ness model will help us face the challenges ahead
- Of course, we continue to be mindful of the broader environment and
uncertainties that go well beyond the war, such as the supply chain is-
sues that could further impact future economic growth
Slide 4 – Positive operating performance
- A key driver of higher profitability is our delivery of positive operating
leverage, which I will now cover on slide 4
- Starting with revenues, Group revenues increased by 1% year on year
and the Core Bank contributed by generating revenues of 7.3 billion eu-
ros, up 3% year on year
- Excluding revenues in Corporate & Other and the Capital Release Unit,
the average annual increase of revenues in the four operating divisions
was 7%
- Revenues in the Corporate Bank were up 11% year on year, a second
consecutive quarter of double-digit growth, driven by continued deposit
repricing and business growth
- Investment Bank revenues grew 7% year on year, over a strong first
quarter in 2021. A 15% increase in FIC revenues more than offset a 28%
decline in Origination and Advisory
- In the Private Bank, continued strong business growth more than offset
interest rate headwinds and, as a result, revenues were up 2% year on
year
- Asset Management revenues rose 7% year on year, driven by a 13% rise
in management fees which reflects consecutive quarters of inflows and
assets under management growth during last year
- Assets under management increased by 82 billion euros year on year to
902 billion euros
- Moving now to costs, noninterest expenses were down 4% year on year,
despite an increase in bank levies of 28%, or more than 150 million euros,

-- 4 of 22 --

which was offset by lower transformation charges and the cessation of
Prime Finance costs
- Adjusted costs excluding bank levies, transformation charges and Prime
Finance were also down 1% year on year reflecting lower investment
spending needs after the completion of IT projects and delivery of effi-
ciency gains, again in line with plan
- Beyond these cost items, we faced higher-than-expected expenses
mainly in compensation costs
Slide 5 – Resilient loan & deposit development
- Let us now look at topics that drive our revenue performance over the
next slides
- Slide 5 provides further details on the development in our loan and de-
posit books over the quarter
- Loan growth across the bank has been 5 billion euros or 2 billion euros
on a FX-adjusted basis
- As outlined in the previous quarter, this normalization in our growth rate
was expected due to a partial reversal of short-term lending which sup-
ported a strategic transaction over year-end in the Investment Bank. We
expect the majority of this loan to be repaid by the end of the second
quarter
- Offsetting this, we saw continued strong momentum from mortgages
and collateralized lending in our Private Bank, high client demand in Cor-
porate Treasury Services as well as loan originations across FIC Financ-
ing
- Despite the more challenging market conditions, we saw a strong per-
formance of our deposit portfolio given the market volatility during the
quarter
- Deposits were broadly stable compared to the previous quarter when ad-
justing for FX as a result of active balance sheet management
- Furthermore, our momentum in repricing deposits has also continued as
shown on slide 6
Slide 6 – Deposit repricing momentum continued in Q1 2022

-- 5 of 22 --

- At the end of the first quarter, we had charging agreements in place on
a total of 142 billion euros of deposits, generating quarterly revenues of
139 million euros
- Compared to the first quarter last year, we implemented additional
agreements on 47 billion euros of deposits
- Our annualized run-rate now stands at 557 million euros, an increase of
149 million euros compared to our full year 2021 charging revenues,
principally driven by ramp-up effects from last year as well as the contin-
ued lowering of charging thresholds
- Looking ahead, current forward curves imply lower charging-specific
revenues later this year which will be more than offset given our overall
positive net interest income sensitivity
Slide 7 – Net interest margin expected to have bottomed in 2021
- Let me provide some detail on the evolution of our net interest margin on
slide 7
- Looking back, the decline of net interest margin in the first half of 2020
was driven by the cut in US rates
- The margin has been broadly stable since then, above the level we ini-
tially anticipated, driven by increased balance sheet efficiency, deposit
repricing and TLTRO income that helped offset ongoing deposit margin
pressure
- Adjusting for TLTRO timing effects, NIM in the first quarter would have
been at the prior year level
- From here, we expect NIM to rise due to the tailwinds from the rising rate
environment
Slide 8 – Strong liquidity position in-line with targets
- Moving to slide 8 highlighting the development of our key liquidity met-
rics
- Despite the recent period of increased market volatility due to the war in
Ukraine, our liquidity and funding levels remain robust and close to tar-
geted levels
- The stock of our high-quality liquid assets increased by about 7 billion
euros during the first quarter

-- 6 of 22 --

- This is mainly due to new issuance activities and deposit inflows primar-
ily from the Private Bank
- The liquidity increase was partially deployed in further loan growth quar-
ter on quarter, primarily in the Private and Corporate Bank
- As a result, the Liquidity Coverage Ratio slightly increased by two per-
centage points to 135%
- The surplus above minimum requirements increased by about 3 billion
euros quarter on quarter to 55 billion euros
- For the remainder of 2022, we remain committed to supporting the busi-
nesses while comfortably exceeding regulatory requirements
- Going forward, we continue to steer the Liquidity Coverage Ratio con-
servatively towards 130%
- The Net Stable Funding Ratio of 121% at quarter-end was broadly un-
changed at the upper bound of our target range, comfortably above the
100% requirement
- The longer-term funding sources for the bank remain well-diversified
and continue to benefit from a strong customer deposit base, which con-
tributes about two thirds to the Group’s available stable funding sources
- For the remainder of the year, we aim to maintain this funding mix, which
will be supplemented by debt securities issued in line with our issuance
plan
Slide 9 – CET1 ratio impacted by higher RWA
- Turning to capital on slide 9
- Our Common Equity Tier 1 ratio decreased from 13.2% to 12.8% over the
quarter, or 41 basis points
- This reflects a decline of around 8 basis points from higher risk weighted
assets due to core bank business growth, partially offset by lower oper-
ational RWA
- ECB-mandated model adjustments related to small and medium-sized
enterprise lending led to a decrease of 20 basis points
- Strong organic capital generation during the quarter was offset by share
repurchases, deductions for dividends, AT1 coupon payments and eq-
uity compensation, adding 4 basis points net
- We estimate the impact of the war in Ukraine on our CET1 ratio as 17
basis points, due to higher risk weights on our Russia-related exposures

-- 7 of 22 --

and higher prudent valuation reserves, due to the increased dispersion
of market prices
- CET1 capital now includes a capital deduction for common share divi-
dends of 354 million euros for 2022, in addition to the roughly 400 million
euros which were already put aside last year to pay the proposed 2021
dividend of 20 cents per share post the Annual General Meeting this May
- We remain committed to support business growth through continued
earnings retention and to finish the year with a CET1 ratio of 13% or
higher
- However, what remains hard to predict at this point is the potential for
further regulatory-driven RWA inflation over the remainder of the year
Slide 10 – Capital ratios well above regulatory requirements
- Our capital ratios remain well above regulatory requirements as shown
on slide 10
- Due to ECB-mandated model adjustments and as a result of the war in
Ukraine, the distance to the CET1 capital requirement has decreased by
41 basis points over the quarter and now stands at 238 basis points or 9
billion euros of regulatory capital
- We have successfully issued two Tier 2 capital instruments with a total
volume of 2.6 billion euros in the quarter and a 750 million euros AT1
capital instrument which has settled on the 4th of April only and is there-
fore not included in the first quarter 2022 statutory capital
- With these issuances we have better aligned our AT1 and Tier 2 capital
structure to regulatory requirements
- As a result, our Total Capital ratio distance to MDA is now 250 basis
points on a pro-forma basis including the latest AT1 issuance
Slide 11 – Leverage ratio improved in Q4
- Moving to slide 11
- Our fully loaded leverage ratio was 4.6%, a decrease of 30 basis points
over the quarter
- Of the 30 basis points decrease, 16 basis points were driven by Tier 1
capital, which reduced as a result of the call of our 1.75 billion euros AT1
instrument announced in January

-- 8 of 22 --

- Our 750 million euros AT1 issuance that settled in early April adds 6 ba-
sis points to our leverage ratio on a pro-forma basis
- Leverage exposure, excluding FX effects, increased by 28 billion euros
quarter on quarter, following continued growth in our Core Bank, includ-
ing loan growth
- Our pro-forma fully loaded leverage ratio including certain ECB cash bal-
ances was 4.3%
- With our reported leverage ratio of 4.6% at the end of the quarter we
have a buffer of 134 basis points over our leverage ratio requirement of
3.23%
Slide 12 – Significant buffer over loss absorbing capacity requirements
- We continue to operate with a significant loss-absorbing capacity, well
above all our requirements, as shown on slide 12
- The MREL surplus, as our most binding constraint, has increased by 1
billion euros to 15 billion euros over the quarter, mainly from the first-
time inclusion of selected structured notes in senior preferred ranking
that meet the MREL eligibility criteria. This has more than offset higher
RWA
- We expect a reduction of the MREL surplus in the second quarter of
2022 given we will receive the next, higher MREL requirement from the
Single Resolution Board
- Our loss-absorbing capacity buffer remains at a comfortable level and
continues to provide us with the flexibility to pause issuing new senior
non-preferred or senior preferred instruments for approximately one
year
Slide 13 – Substantial portion of issuance plan already achieved in Q1
- Moving now to our issuance plan on slide 13
- In the first quarter, we issued a total of 8 billion euros, mainly driven by
five benchmark issuances as well as larger structured issuances
- Our last two benchmark transactions were a 1.5 billion euros Tier 2 and
a 750 million euros AT1 security. Both deals combined saw an aggregate
orderbook of over 12 billion euros

-- 9 of 22 --

- Together with the AT1 issuance in November last year, we have raised
4.6 billion euros of new capital instruments to strengthen our balance
sheet. Most of our requirements for 2022 are now satisfied
- Also noteworthy was our first green senior non-preferred issuance over
1.25 billion euros. This expands our ESG issuance footprint into a new
debt class
- As you are aware, we have not called Postbank Funding Trusts I and III,
despite their loss of recognition as regulatory capital. We continue to see
these bonds as inexpensive funding instruments for our balance sheet
- We will continue to make decisions regarding the exercise of the issuer
call right depending on economic factors while balancing the interests of
our key stakeholders
- For the full year, our issuance plan remains between 15 and 20 billion
euros
- Despite the challenging market environment in this quarter, we have al-
ready completed over 50 percent of the lower end of our full-year issu-
ance target
Slide 14 – Outlook
- Turning to the outlook on slide 14
- The current geopolitical outlook and macro-economic environment
brings a great deal of uncertainty to the financial markets and to our cli-
ents
- However, strong revenue momentum in our core businesses continues
to support our revenue guidance of 26 to 27 billion euros for 2022 and,
in our view, our first quarter results built a strong foundation to achieve
this
- We remain highly focused on cost discipline and continue to work to-
wards our targets, but the current environment remains challenging and
the visible cost pressures have intensified
- We remain disciplined in managing our risks and we believe that near-
term risk is contained
- Our capital remains resilient as our organic capital generation was offset
by distributions, while at the same time we supported business growth
and absorbed regulatory changes and the impact of the war
- We remain confident in our year-end guidance of around 13%, consistent
with our target of greater than 12.5%

-- 10 of 22 --

- Our strong first quarter also gives us flexibility on issuance for the re-
mainder of the year
- With that we look forward to your questions
Question and answer session
James von Moltke Before we do the Q&A, I just wanted to make a brief
statement. You will have seen the headlines today with
regard to searches by the Frankfurt Public Prosecutor in
our Frankfurt head office. As you may have read from
our statements, this is an investigative measure in con-
nection with suspicious activity reported by the bank.
Deutsche Bank is fully cooperating with the authorities.
Unfortunately, as this event is very recent and an ongo-
ing investigation, we are unable to say more on this mat-
ter on today’s call. With that, we look forward to your
questions.
Robert Smalley
(UBS)
Good morning and thanks for doing the call. A couple of
related questions on credit and credit quality. Can you
talk about the leverage lending book? When I look on
slide 26, I see that the notional hasn’t changed that
much, but when we’re looking at provisioning, looking at
risk, capital allocation to the book, could you talk about
how you may be looking at that differently in a rising rate
environment, particularly.
Secondly, on the call from the other day, there was a dis-
cussion of loan growth in trade finance. Could you talk
about that? That’s the other end of the credit spectrum,
but what are the opportunities there and what does that
do around RWAs and density, if anything different?
And then finally, trying to pull it together, as we look at
the loan portfolio going forward, should we look at your
loan portfolio as growing more barbelled will more lever-
age exposure and more low-risk trade finance, and not
as much in the middle? How do we dimension that
across the credit spectrum? Thanks.

-- 11 of 22 --

James von Moltke Hi, Robert. Thank you for joining the call. It’s James
here. Obviously, the growth year on year in the Invest-
ment Bank loan book was considerable, so I think your
question is entirely well placed. One element of that
growth relates to an episodic transaction, which we
called out in the Q4 earnings call that we expected to run
off.
And it did partially run off, but some of it was still on the
books on March 31st. If you adjust for that, the growth
is in the financing part of our business and is significant
year on year, but relates to, essentially, regrowing our
structured finance portfolio in that lending business.
Leveraged lending, that book has been relatively flat
over time.
We managed that book within quite disciplined risk ap-
petite metrics and constraints, and actually, as you
know, volumes, relatively speaking, were weaker in the
first quarter than over recent quarters. So, you would not
have seen leveraged lending being a significant contrib-
utor to that loan growth sequentially.
On the trade finance part, that is obviously a business
we think we have leading capabilities in, and it is a core
part of our strategy going forward in the Corporate
Bank. Those are attractive assets, in terms of their char-
acteristics in a variety of ways, including their risk char-
acteristics. And indeed, we do intend to grow our trade
finance book.
The trends, as I mentioned on Wednesday, are encour-
aging in that regard. Notably that a longer, more compli-
cated supply chain increases the need for working capi-
tal, increases the length of inventory flows in the econ-
omy, which is something that needs to be financed.
The last point barbells. We do think of our portfolio as a
barbell, but the whole loan book. And you need to re-
member that a significant part of the loan book is in the
retail banking part of the business, and within that, heav-
ily weighted towards mortgages. And the types of lend-
ing, you’re talking about leveraged lending or some of
the structured finance, we think we do really well in and

-- 12 of 22 --

have a very good handle on the risks and a very solid risk
performance over time in those activities.
As you say, it is balanced by a much larger, very low-risk,
highly secured book that we run within that total 480 bil-
lion of loans. I hope that helps in terms of colour, Robert,
on your question.
Robert Smalley
(UBS)
Very much. Thanks a lot, and thanks for doing the call.
Jakub Lichwa
(Goldman Sachs)
Hi there. I’ve got a few questions. Thanks for doing the
call, as always.
Question number one is you have reduced fairly recently
the prime broking business. Would you actually expect
that to have any effect on reduction in your market risk?
And also, would this leak through, you would expect into
Pillar 2 assessments for the following year or not?
The second one is resolution planning. Is there any date
by which the authorities expect you to present or com-
plete the resolution planning? I think there are expecta-
tions for banks. There is an indicative date of end of
2023, by which point, banks should remove any sort of
impediment to resolvability, or SPV issued instruments,
etc.
On ratings, question number three, you’re on a positive
outlook from Moody’s. Clearly, the beneficiary there is a
tier two rating. But beyond tier two, obviously, your issu-
ance right now at the senior non-preferred levels cali-
brated to LGF, in order to qualify for that one notch. Do
you expect to be defending that one notch in case of an
upgrade? Or would you be happy with B double A2 rat-
ing at the senior non-preferred level? So, would you
think that you may reduce the stock or senior non-pre-
ferred debt? And is this actually already in your funding
plan? That’s number three.
And number four, on the CMS, sorry to ask, I know it’s
small security, but SRB seems to allow SPV issued debt

-- 13 of 22 --

in MREL. As long as they do not pose an operational is-
sue in resolution. Can you confirm to us whether CNS
poses issues in resolution planning, please? Thank you.
James von Moltke Thanks for your questions. I’m going to take the first two,
it’s James, and then Dixit will take the second two. On
prime brokerage, that is out of our balance sheet, P&L,
and our risk metrics now, from the first of the year. It had
tailed off towards the end of last year as we transferred,
client by client, over to BNP Paribas.
But all of our metrics, recruiting metrics, market risk
metrics, obviously, the leverage balance sheet, and the
balance sheet are clean from an influence of Prime Fi-
nance at this point. The one thing, as you know with any
of the businesses that we exit, there can be operational
risk RWA that stay with us, but beyond that, it is not part
of our profile today.
On the Pillar 2 requirement, business model is one of the
considerations of your Pillar 2 setting. I can’t speak for
the assessment, and certainly not publicly, but it does
feed in, naturally, to the Pillar 2 assessment on business
model.
On resolution planning, as you say, the measurement
date in an end-2023 assessment of your resolvability
that the Single Resolution Board has to determine in
connection, also, with the national resolution regulators.
This has been a build over many years, and as a firm,
we’re highly committed to building all of the capabilities
across the full range and dimension of resolution capa-
bilities, in order to achieve a positive assessment by the
end of 2023. For practical purposes, we feel that those
capabilities have to be in place by the end of this year to
prove their sustainability over time.
So, we’re working towards a 2022 timeline to have all, or
practically all, of the capabilities in place, hopefully,
meeting the expectations of our resolution authorities.
Dixit Joshi I’ll take the last two. On ratings, in the current moment,
we don’t anticipate giving up the senior non-preferred

-- 14 of 22 --

LGF uplift. We’ve been encouraged by the upgrades that
we’ve got from all three agencies in 2021, I would say,
hard won through many quarters of consistent execu-
tion on our transformation plan. We’re on the right track,
we think there is positive momentum and positive rat-
ings pressure in respect of us, which is a good thing. But
we don’t plan to give up the uplift.
In terms of legacy AT1, you’ll see, in the appendix, we
have a list of our capital instruments. It does not include
the two issuances that add up to about 600 million in ag-
gregate, i.e., a de minimis amount. But we don’t see
those as an impediment to resolution. We’ve done a
thorough legal analysis there and those two instruments
for us are simply now cheap funding, and we’ve kept
those outstanding. I hope that’s helpful.
Jakub Lichwa
(Goldman Sachs)
Yes, thank you.
Stéphane Suchet
(Credit Suisse)
Thank you very much for the call. Three questions, if I
may, on my side. The first one is what has been the im-
pact of rising rates on your other comprehensive income
and how do you compare to peers?
The second question is probably a product question re-
garding the ECB response to the European Commis-
sion’s call for advice on the macroprudential framework,
and more specifically, on AT1. How to make AT1 securi-
ties more of a going concern capital and make coupon
payments easier to cancel. What is your thinking on
that?
And lastly, what is your thinking in terms of timeframe
for a ratings upgrade, especially at Moody’s? Any insight
you could share with us would be much appreciated in
this respect. Thank you.
Dixit Joshi Sure, Stéphane, I’m happy to run through that. In turn,
on the OCI front, we have noted that peers have had rea-
sonably large OCI losses in the first quarter as a result of
the rate environment. The impact for us was more meas-
ured. It was probably in the region of less than, I would
estimate, around 300 million euros after some technical

-- 15 of 22 --

effects. Probably around in the region of five basis
points of CET1.
And within that, I would say the specific element related
to securities portfolios within our liquidity results would
probably be about 50 million in the quarter. And the rea-
son we’ve seen a muted CET1 drawdown in the first
quarter, even though we’ve had fairly large moves in in-
terest rates is we had de-risked portfolios coming into
the close of last year.
And that was as a result of our view that we entered
2022 see higher volatility and a steeper curve and higher
rates, again, with lots of uncertainty and uncertainty
around timing as well. And that prudent risk manage-
ment has helped put us in good stead.
On the ECB consultation, call for advice, and on AT1, is
something that we obviously follow very closely and par-
ticipate in. And it is our view that to the extent that reg-
ulators look to review methodology, review the toolkit
around capital, look at making it further risk sensitive
and efficient, we obviously encourage improvements to
the framework. Ultimately, it is, of course, in the domain
of the legislators to decide what that framework looks
like.
I would think that this would be in the context of wider
discussion around bank capital and the bank capital
stack. You would have noted the comments out of the
PRA, which we are also following reasonably closely. So,
I would say look, the AT1 market, currently, as you know,
is fairly well-structured, well understood. We’ve issued
in full compliance with the guidelines around structuring
of AT1 instruments, so investors are reasonably com-
fortable with the current market. That’s not to say the
marketplace can’t be enhanced.
And then the third question you had around ratings,
again, there’s not a whole lot to say, given it’s not really
in our domain and timeline to control. But we’re encour-
aged. We remain on a positive outlook. We continue to
execute on our transformation plan, which is one of the
key criteria the ratings agencies have. So, we’re going to

-- 16 of 22 --

continue doing what we’ve done now for many quarters.
One, a prudent balance sheet, ensure that we communi-
cate very carefully and transparently with the capital
markets to try and minimise our issuance needs, and
continue to execute successfully with some upward
pressure on our ratings from here. I hope that’s helpful.
Stéphane Suchet
(Credit Suisse)
Yes, indeed. Thank you very much.
Lee Street
(Citigroup)
Good afternoon and thank you for taking my question.
I’ve only got one, but there’s a couple of parts to it. If
Russian gas and oil gets switched off in Germany and we
get the type of GDP reduction that the Bundesbank is
suggesting, and then a potential recession, A, do you still
think Deutsche Bank can achieve its 8% return on tangi-
ble equity target for the year?
Obviously, I appreciate that the German state probably
comes in with some capital injections, KfW does some
lending, but my worry is that it probably stops the re-
quired loan growth in your private clients and your cor-
porate divisions, where you probably still get the cost
pressure, and you might not get as many rate rises com-
ing through.
That’s question one, and then linked to that in that sce-
nario, what levers do you have to pull to help you get
back up or achieve that 8%? So, it’s basically all about
economic risk and the risk that that impenetrability to hit
your 8% return on tangible equity target. That would be
my question.
James von Moltke Thanks, Lee. I appreciate the question. As we’ve said
now for three years, we have been doing everything to
manage the company towards the financial targets that
we set for 2022. Over that period of time, we’ve over-
come a number of different challenges in the market-
place, or the market environment and the economic en-
vironment, and we’ve remained committed to doing
that.
As we disclosed on Wednesday, we continue to see a
path to our targets for this year. No question that there’s

-- 17 of 22 --

a scenario, an adverse scenario, that can take place that
would make it increasingly challenging to hit those tar-
gets. But as we sit here today, we don’t see that scenario
materialising. It’s not our base case. And we’ve been
working to create the levers necessary to retain the path.
In terms of this scenario, as I say, it’s not our base case
that that takes place. We agree with the Bundesbank
analysis in terms of the severity of the impact on the Ger-
many economy, but as you say, the potential offsets,
whether it’s fiscal support from the German government
for the economy, where we do believe there is political
will and the resources to do that. It’s frankly not easy to
predict how these scenarios play to.
But there is clearly a downside scenario that would put
more pressure on that target achievement.
Lee Street
(Citigroup)
Any particular levers you might have in those scenarios?
Anything you could call out?
James von Moltke The levers are the ones that are in place. As I said on
Wednesday to, I think, Stuart Graham’s question, the
ECL impact for us, even in that downside scenario, looks
to be, in some sense, surprisingly modest as we sit here
today. And there is no inclination in our credit book that
there’s a deterioration so far as a result of these events.
And the first level is, of course, having a strong and well
underwritten credit book with the right degree of diver-
sification, low concentration risks, credit protection,
where it’s applicable, and just managing the business
carefully and within risk appetite. So, in that sense, that
lever is already pulled.
And then we’re working on, with respect to the rest of
our income statement and balance sheet, to manage to-
wards the targets. So, I think, as a management team,
we’re doing everything we can to remain on track and
managing through this environment with the appropri-
ate degree of caution, but also, cognisant that it’s not our
base case and that we remain on track against our ob-
jectives for the year.

-- 18 of 22 --

Lee Street
(Citigroup)
Thank you very much for the response.
Daniel David
(Autonomous)
Good afternoon. Thanks for the call and taking my ques-
tions, I’ve just got a couple. On RWAs, I think you’ve
guided to 415 to 420 billion in 2025. Now that there may
be five to ten billion of RWA inflation in 2022, due to the
ECB model decisions on the SME book and the retail
book, is the 415 to 420 still unchanged? Or is there any-
thing else to say there?
And related to that, does the ECB model decision mean
that the 10% RWA inflation guided to for Basel IV come
down a bit, or is there anything else that you could say
on that?
And finally, on the CMS, and again, I know it’s been
talked about and apologies for returning to the topic, I
understand that German BRRD transposition has an im-
pact on the CMS and infection risk that’s perhaps been
talked to death. But I just wanted to understand, does
German BRRD mean that there isn’t infection risk for the
MREL layer? And with regard to your comments on de
minimis, is that sentiment also shared by the regulator,
or should we read that the EFB, the expectation for
banks is when they’ll give that kind of sign-off? Thanks.
James von Moltke On the RWA side, no change in our view for 2025. First
of all, at least the first of these model adjustments was
built into our planning. And then secondly, the effect of
a lot of these model decisions is simply to raise the IRB
RWA, ultimately, given that, over time, and this is really
in 2029, when the output floor becomes binding, all it
does is really bring forward or cause to converge slightly
the IRB and the standardised approaches, so that the ul-
timate result of the output floor is less. As we think about
2025, as I say, at this order of magnitude, it doesn’t af-
fect our capital planning.
Dixit Joshi Hi. On the BRRD and infection risk, again, in our view,
just given the nature of our capital set, we really don’t
have much exposure, even if you consider the two notes
that we have, which again, having done the legal work

-- 19 of 22 --

around those, we don’t view our stack as having infec-
tion risk, and certainly not from an MREL point of view.
Daniel David
(Autonomous)
Thanks. And just to touch on the point on de minimis, is
that signed off by the regulator that it’s not a problem,
or is that something that is yet to come?
Dixit Joshi I think the BRRD is reasonably clear in our minds, and
so, having done the work around those notes, it’s pretty
clear to us that we don’t have that infection risk. I can’t
comment on the regulator review here, but from our per-
spective, we’ve managed our stack with that assess-
ment in mind.
Daniel David
(Autonomous)
Understood, thank you.
James Hyde
(PGIM)
Good afternoon. Two questions. One on litigation risk
and I’m not asking about today’s raid. I’m looking at you
have 1.1 billion of litigation reserves, and then there is
this figure that hasn’t changed about the 1.7 billion of
possible that you have this usual language about.
I’m just wondering, although these are way below any-
thing that was paid out in the DOJ RMBS business and
so forth, beyond maybe hitting 2022 target 8%, what
would be your annual budget for topping this up or for
just operational risks that arise? What are your expecta-
tions on that? Also, can you confirm that you are com-
pletely done with Cum-Ex, with that little fine you had a
couple of years back?
Then secondly, on credit risk, about 40% coverage of all
stage threes by all provisions, which has not really
changed that much for you over time. But I still don’t un-
derstand how that works with calendar provisioning. Is
it something that is going to be constantly deducted
from CET1? Or just going to keep doing your Pillar 2 re-
quirement higher? Those are my two questions. Thanks.
James von Moltke James, it’s James. I’ll take both, but feel free to ask a fol-
low-up. So, on litigation risk, you notice how relatively

-- 20 of 22 --

stable the provisions have been in the past recent quar-
ters, both the balance sheet provision and the contin-
gent liability or contingent risk that we see.
And that reflects that there haven’t been any major
items either flowing in or flowing out of our litigation
portfolio. By and large, that’s a good thing. I think a de-
gree of stability there is helpful, although as you know,
from our disclosure, there are one or two matters that we
would happily resolve and put behind us.
In terms of the ongoing, it’s always hard to say. It’s an
awkward thing to talk about what is your, quote unquote,
budget for litigation matters? Our goal, and you’ve heard
us talk a lot about investing in our control environment
and our operational or non-financial risk management
capabilities and what have you, the goal is obviously to
conduct our business in the best possible way, so as to
minimise the degree of litigation risk that we face.
In our business, of course, that’s never zero, but if you’re
looking for a budget, it’s considerably smaller than the
worst of the years we’ve had, and probably towards the
single-digit 100 millions and the low end of that, to the
extent that we can, again, benefit from the longstanding
investments in non-financial risk management, and also,
conduct and other aspects of our business.
In terms of the deduction from CET1, if I understood the
question correctly, I think it’s really the ECL that you’re
thinking about in this regard that feeds into our regula-
tory capital that ebbs and flows, based on, essentially,
the book evolution, and then also, the risk evolution, in
particular, ratings migration, model changes, and as-
sessment to the riskiness and the environment.
So, it’s not a constant number, for sure. Hopefully, I’ve
understood your question correctly. If not, feel free to
ask a follow-up.
James Hyde
(PGIM)
Thanks. It’s to do with the calendar provision require-
ments for stale non-performing loans.

-- 21 of 22 --

James von Moltke I understand the question now. The NPE: we have been
incrementing, over time, the capital impact of the non-
performing exposure backstop requirement that the
ECB has communicated to the banks. So, yes, that’s
built into it. To my knowledge, we’re now fully built, I be-
lieve, in terms of the capital impact of the NPE backstop.
James Hyde
(PGIM)
Thank you, James.
Philip Teuchner Thank you. And just to finish up, thank you all for joining
us today. You know where the IR team is, if you have any
further questions. We look forward to talking to you soon
again. Goodbye.
Disclaimer
This transcript contains forward-looking statements. Forward-looking statements are statements
that are not historical facts; they include statements about our beliefs and expectations and the as-
sumptions underlying them. These statements are based on plans, estimates and projections as they
are currently available to the management of Deutsche Bank. Forward-looking statements therefore
speak only as of the date they are made, and we undertake no obligation to update publicly any of
them in light of new information or future events.
By their very nature, forward-looking statements involve risks and uncertainties. A number of im-
portant factors could therefore cause actual results to differ materially from those contained in any
forward-looking statement. Such factors include the conditions in the financial markets in Germany,
in Europe, in the United States and elsewhere from which we derive a substantial portion of our
revenues and in which we hold a substantial portion of our assets, the development of asset prices
and market volatility, potential defaults of borrowers or trading counterparties, the implementation
of our strategic initiatives, the reliability of our risk management policies, procedures and methods,
and other risks referenced in our filings with the U.S. Securities and Exchange Commission. Such
factors are described in detail in our most recent SEC Form under the heading “Risk Factors.” Cop-
ies of this document are readily available upon request or can be downloaded from investor-rela-
tions.db.com.
This transcript also contains non-IFRS financial measures. For a reconciliation to directly compara-
ble figures reported under IFRS, to the extent such reconciliation is not provided in this transcript,
refer to the Q1 2022 Financial Data Supplement, which is available at investor-relations.db.com.
This transcript is provided solely for information purposes and shall not be construed as a solicitation
of an offer to buy or sell any securities or other financial instruments in any jurisdiction. No invest-
ment decision relating to securities of or relating to Deutsche Bank AG or its affiliates should be
made on the basis of this document. Please refer to Deutsche Bank’s annual and interim reports, ad
hoc announcements under Article 17 of Regulation (EU) No. 596/2014 and filings with the U.S. Se-
curities Exchange Commission (SEC) under Form 6-K.

-- 22 of 22 --